Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

Literature DB >> 16369038

Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

Rosalind Polley¹, Simona Stager, Sara Prickett, Asher Maroof, Soombul Zubairi, Deborah F Smith, Paul M Kaye.

Abstract

CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.

Entities: Chemical

Mesh：

Substances：

Year: 2006 PMID： 16369038 PMCID： PMC1346645 DOI： 10.1128/IAI.74.1.773-776.2006

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

25 in total

1. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors: F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal: Nature Date: 1999-10-14 Impact factor: 49.962

2. IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells.

Authors: O F Bathe; N Dalyot-Herman; T R Malek
Journal: J Immunol Date: 2001-10-15 Impact factor: 5.422

3. Phagosomes are competent organelles for antigen cross-presentation.

Authors: Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F Princiotta; Pierre Thibault; David Sacks; Michel Desjardins
Journal: Nature Date: 2003-09-25 Impact factor: 49.962

4. Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

Authors: Simona Stäger; James Alexander; Alun C Kirby; Marina Botto; Nico Van Rooijen; Deborah F Smith; Frank Brombacher; Paul M Kaye
Journal: Nat Med Date: 2003-09-21 Impact factor: 53.440

5. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.

Authors: Rosalind Polley; Stephanie L Sanos; Sara Prickett; Ashraful Haque; Paul M Kaye
Journal: Infect Immun Date: 2005-12 Impact factor: 3.441

6. Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes.

Authors: A Misslitz; J C Mottram; P Overath; T Aebischer
Journal: Mol Biochem Parasitol Date: 2000-04-15 Impact factor: 1.759

7. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens.

Authors: G Lertmemongkolchai; G Cai; C A Hunter; G J Bancroft
Journal: J Immunol Date: 2001-01-15 Impact factor: 5.422

8. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Authors: Yasmine Belkaid; Esther Von Stebut; Susana Mendez; Rosalia Lira; Elisabet Caler; Sylvie Bertholet; Mark C Udey; David Sacks
Journal: J Immunol Date: 2002-04-15 Impact factor: 5.422

9. Migratory properties of naive, effector, and memory CD8(+) T cells.

Authors: W Weninger; M A Crowley; N Manjunath; U H von Andrian
Journal: J Exp Med Date: 2001-10-01 Impact factor: 14.307

10. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen.

Authors: Rance E Berg; Emily Crossley; Sean Murray; James Forman
Journal: J Exp Med Date: 2003-11-17 Impact factor: 14.307

28 in total

1. Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors: Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal: Eur J Immunol Date: 2009-01 Impact factor: 5.532

2. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.

Authors: Rosalind Polley; Stephanie L Sanos; Sara Prickett; Ashraful Haque; Paul M Kaye
Journal: Infect Immun Date: 2005-12 Impact factor: 3.441

3. Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.

Authors: Levi Eduardo Soares Reis; Rory Cristiane Fortes de Brito; Jamille Mirelle de Oliveira Cardoso; Fernando Augusto Siqueira Mathias; Rodrigo Dian Oliveira Aguiar Soares; Claudia Martins Carneiro; Paula Melo de Abreu Vieira; Guilherme Santos Ramos; Frédéric Jean Georges Frézard; Bruno Mendes Roatt; Alexandre Barbosa Reis
Journal: Antimicrob Agents Chemother Date: 2017-10-24 Impact factor: 5.191

4. Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.

Authors: Henry W Murray; Marisa Mitchell-Flack; Hua Zheng; Xiaojing Ma
Journal: Infect Immun Date: 2014-12-01 Impact factor: 3.441

5. Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.

Authors: Lynette Beattie; Adam Peltan; Asher Maroof; Alun Kirby; Najmeeyah Brown; Mark Coles; Deborah F Smith; Paul M Kaye
Journal: PLoS Pathog Date: 2010-03-12 Impact factor: 6.823

6. Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses.

Authors: Helen M Rowe; Luciene Lopes; Najmeeyah Brown; Sofia Efklidou; Timothy Smallie; Sarah Karrar; Paul M Kaye; Mary K Collins
Journal: J Virol Date: 2008-11-26 Impact factor: 5.103

Review 7. HLA and infectious diseases.

Authors: Jenefer M Blackwell; Sarra E Jamieson; David Burgner
Journal: Clin Microbiol Rev Date: 2009-04 Impact factor: 26.132